The TIMER database analysis revealed that BTLA mRNA expression was lower in bladder cancer (BLCA), colon adenocarcinoma (COAD), lung squamous cell carcinoma (LUSC), rectum adenocarcinoma (READ), and thyroid carcinoma (THCA) compared with adjacent normal tissues. This evidence concerns the gene BTLA and rectum adenocarcinoma.